Yao Anjie, Liu Zixuan, He Wenni, Rao Hanyu, Wang Changhui, Xie Shuanshuan
Department of Respiratory Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.
School of Medicine, Tongji University, Shanghai 200092, China.
Diagnostics (Basel). 2023 Oct 22;13(20):3276. doi: 10.3390/diagnostics13203276.
(1) Background: The aim of our study is to investigate the effectiveness of bronchoscopic airway clearance therapy (B-ACT) on severe pneumonia (SP) patients with invasive mechanical ventilation (IMV) in the intensive care unit (ICU). (2) Methods: Our study retrospectively enrolled 49 patients with sputum aspiration and 99 patients with B-ACT, and the latter were divided into the ≤once every 3 days group ( = 50) and >once every 3 days group ( = 49). (3) Results: We found most laboratory blood results were significantly improved in the B-ACT group as compared with those in sputum aspiration group ( < 0.05). Patients in the B-ACT group and those in ≤once every 3 days group also had significantly better survival to hospital discharge than those in their counterpart groups (Logrank < 0.001). In patients with cardiopulmonary diseases or positive cultures for bacteria, the B-ACT group and those in the ≤once every 3 days group had significantly better survival outcomes to discharge than those in their counterpart groups (Logrank < 0.001). B-ACT and the average frequency of ≤once every 3 days had significantly better impact on survival outcomes than their counterpart groups (HR: 0.444, 95% CI: 0.238-0.829, = 0.011; HR: 0.285, 95% CI: 0163-0.498, < 0.001). (4) Conclusions: In the future, flexible bronchoscopes may paly an important role in ACT for SP patients with IMV.
(1) 背景:我们研究的目的是调查支气管镜气道清除疗法(B-ACT)对重症监护病房(ICU)中接受有创机械通气(IMV)的重症肺炎(SP)患者的有效性。(2) 方法:我们的研究回顾性纳入了49例痰吸引患者和99例接受B-ACT的患者,后者被分为每3天≤1次组(n = 50)和每3天>1次组(n = 49)。(3) 结果:我们发现,与痰吸引组相比,B-ACT组的大多数实验室血液检查结果有显著改善(P < 0.05)。B-ACT组患者和每3天≤1次组患者出院生存率也显著高于各自的对照组(对数秩检验P < 0.001)。在患有心肺疾病或细菌培养阳性的患者中,B-ACT组和每3天≤1次组患者出院生存结局显著优于各自的对照组(对数秩检验P < 0.001)。B-ACT和每3天≤1次的平均频率对生存结局的影响显著优于各自的对照组(风险比:0.444,95%置信区间:0.238 - 0.829,P = 0.011;风险比:0.285,95%置信区间:0.163 - 0.498,P < 0.001)。(4) 结论:未来,可弯曲支气管镜可能在对接受IMV的SP患者的气道清除疗法中发挥重要作用。